Biogen Idec wins Canadian approval for hemophilia drug Alprolix

(Reuters) - Biogen Idec Inc said on Friday it had won Canadian approval for its long-lasting hemophilia B drug Alprolix.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news